OP1 |
These recommendations refer to the definition of systemic sclerosis–related primary heart involvement (SSc-pHI)
9
|
12 |
8.42 |
17 |
OP2 |
SSc-pHI should be considered particularly in the early stages of the disease, but it may also be present and develop throughout the disease course of a patient with SSc |
13 |
9.38 |
8 |
OP3 |
The patient should be counseled about the symptoms and consequences of SSc-pHI to raise their awareness and to ensure the importance of reporting symptoms to the physician |
14 |
9.71 |
7 |
OP4 |
Where suspicion for SSc-pHI exists, acute and chronic coronary syndromes should be considered and managed in line with current guidelines |
14 |
9.21 |
0 |
OP5 |
The differential diagnosis and management of SSc-pHI should be undertaken by a multi-disciplinary team that comprises cardiologist(s) (with necessary subspecialist expertise as indicated) and rheumatologists with SSc expertise |
15 |
9.00 |
7 |
OP6 |
Screening refers to the assessment of asymptomatic patients with no known SSc-pHI, who can be further stratified into those who are considered “at higher risk” and those who should be considered “at lower risk” of developing heart involvement |
14 |
8.43 |
14 |
OP7 |
Diagnosis refers to the assessment of patients presenting with symptoms and/or signs and/or investigations compatible with possible SSc-pHI |
15 |
8.47 |
13 |